Stock Code: 300253 Stock Abbreviation: Wining Health Announcement No.: 2026-040 Wining Health Technology Group Co., Ltd. Announcement of Resolutions of the 29th Meeting of the 6th Board of Directors
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are free from any false representations, misleading statements, or material omissions.
Wining Health Technology Group Co., Ltd. (hereinafter referred to as the "Company") held the 29th meeting of the 6th Board of Directors on April 13, 2026, at the Company's meeting room through a combination of on-site and teleconference voting. The meeting notice was sent by special delivery or email on April 2, 2026. An additional notice for temporary agenda items was sent by email on April 9, 2026. Seven directors were required to attend, and seven directors were actually present. The convening and holding of this Board meeting comply with the "Company Law of the People's Republic of China" and the "Articles of Association" of the Company. The meeting was presided over by Chairman Liu Ning, and senior management personnel of the Company attended the meeting.
After a vote by all directors, the following resolutions were formed:
I. The resolution on the "Proposal on the Company's 2025 General Manager's Work Report" was reviewed and approved with 7 votes in favor, 0 votes against, and 0 abstentions.
II. The resolution on the "Proposal on the Company's 2025 Board of Directors' Work Report" was reviewed and approved with 7 votes in favor, 0 votes against, and 0 abstentions.
Independent Directors Wang Song, Feng Jinfeng, and Yu Jianspring submitted their "2025 Independent Directors' Performance Reports" to the Board of Directors, and will report on their performance at the 2025 Shareholders' Meeting. This proposal still needs to be submitted to the Company's Shareholders' Meeting for review. The "2025 Board of Directors' Work Report" and "2025 Independent Directors' Performance Reports" were disclosed on the same day on the GEM Information Disclosure website designated by the China Securities Regulatory Commission.
III. The resolution on the "Proposal on the Company's 2025 Annual Report and its Summary" was reviewed and approved with 7 votes in favor, 0 votes against, and 0 abstentions.
After review, the Board of Directors believes that the "2025 Annual Report Full Text" and its summary compiled by the Company comply with the requirements of relevant laws, regulations, and normative documents. The report content is true, accurate, and complete, fully reflecting the Company's financial status and operating results for 2025, and is free from any false representations, misleading statements, or material omissions. The Company's Audit Committee has reviewed and approved this proposal. This proposal still needs to be submitted to the Company's Shareholders' Meeting for review. The "2025 Annual Report" and "2025 Annual Report Summary" were disclosed on the same day on the GEM Information Disclosure website designated by the China Securities Regulatory Commission.
IV. The resolution on the "Proposal on the Company's 2025 Profit Distribution Plan" was reviewed and approved with 7 votes in favor, 0 votes against, and 0 abstentions. Given that the Company's net profit for 2025 is negative, and considering the actual operating development and capital needs, in order to better protect the long-term interests of all shareholders, the Company's Board of Directors proposes the 2025 profit distribution plan as follows: no cash dividends, no bonus shares, and no capital reserve to increase share capital for 2025. The Company's Audit Committee has reviewed and approved this proposal. This proposal still needs to be submitted to the Company's Shareholders' Meeting for review. The "Special Explanation on the Company's Decision Not to Distribute Profits for 2025" was disclosed on the same day on the GEM Information Disclosure website designated by the China Securities Regulatory Commission.